Singh Sandeep, Singh Abhay Kumar, Bhushan Manindra, Sen Supratik, Singh Raj Pal, Vijay Anuj, Gairola Munish
Department of Radiation Oncology, Division of Medical Physics, Rajiv Gandhi Cancer Institute and Research Center, New Delhi, New Delhi, India.
Department of Physics, GLA University, Mathura, Uttar Pradesh,, Mathura, India.
J Egypt Natl Canc Inst. 2025 Sep 1;37(1):57. doi: 10.1186/s43046-025-00314-x.
This study aimed to evaluate the multifaceted clinical utility of the RUBY phantom as a comprehensive quality assurance (QA) platform in high-precision radiotherapy, particularly for stereotactic radiosurgery (SRS) and stereotactic radiotherapy (SRT). The objective was to validate its performance in patient positioning, imaging system accuracy, isocenter congruency, and treatment plan verification across various complex clinical scenarios.
A series of QA workflows were conducted using the RUBY phantom and its dedicated modular inserts. These included CBCT and MV/kV planar imaging for patient alignment, the Winston-Lutz insert for isocenter verification, end-to-end testing for full-chain validation, and multi-metastasis and patient-specific inserts for point dose verification. Plans were created in Eclipse TPS (v15.6) and delivered using a Varian TrueBeam STx linear accelerator with high-definition MLC. PTW Semiflex 3D and PinPoint 3D ionization chambers were used for all dosimetric verifications.
CBCT- and planar image-guided alignments showed sub-millimetric deviations, with post-correction alignment verified through coincident laser and surface markers. Winston-Lutz testing across various angles demonstrated maximal deviations of ≤ 0.4 mm, which was within TG-142 recommendations. Point dose measurements for 61 SRS plans showed agreement within ± 3% of TPS calculations. End-to-end testing revealed dose discrepancies of < 1% in both coplanar and non-coplanar beam arrangements. Multi-target plans using single- and multi-isocenter approaches showed deviations of - 0.23% to - 0.50%, confirming excellent dosimetric and geometric accuracy.
The RUBY phantom demonstrated exceptional precision, reproducibility, and clinical adaptability across a spectrum of advanced radiotherapy QA tasks. Its integration enables the end-to-end validation of modern treatment protocols, ensuring alignment, imaging, and accuracy of dose delivery. These findings establish the RUBY phantom as a cornerstone QA solution for enhancing safety, efficacy, and reliability in high-precision radiotherapy.
本研究旨在评估RUBY体模作为高精度放射治疗中综合质量保证(QA)平台的多方面临床效用,特别是对于立体定向放射外科(SRS)和立体定向放射治疗(SRT)。目的是验证其在各种复杂临床场景下的患者定位、成像系统准确性、等中心一致性和治疗计划验证方面的性能。
使用RUBY体模及其专用模块化插件进行了一系列QA工作流程。这些包括用于患者对齐的CBCT和MV/kV平面成像、用于等中心验证的温斯顿-卢茨插件、用于全链验证的端到端测试,以及用于点剂量验证的多转移灶和患者专用插件。在Eclipse TPS(v15.6)中创建计划,并使用配备高清MLC的Varian TrueBeam STx直线加速器进行交付。所有剂量验证均使用PTW Semiflex 3D和PinPoint 3D电离室。
CBCT和平面图像引导对齐显示亚毫米级偏差,通过重合激光和表面标记验证校正后对齐。在各个角度进行的温斯顿-卢茨测试显示最大偏差≤0.4毫米,符合TG-142建议。61个SRS计划的点剂量测量结果与TPS计算结果的一致性在±3%以内。端到端测试显示共面和非共面射束排列中的剂量差异均<1%。使用单等中心和多等中心方法的多靶区计划显示偏差为-0.23%至-0.50%,证实了出色的剂量和几何准确性。
RUBY体模在一系列先进放射治疗QA任务中表现出卓越的精度、可重复性和临床适应性。其集成实现了现代治疗方案的端到端验证,确保了对齐、成像和剂量输送的准确性。这些发现确立了RUBY体模作为提高高精度放射治疗安全性、有效性和可靠性的基石QA解决方案。